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ABSTRACT 
 
The gene(s) encoding enzyme(s) involved in the initial reaction during degradation of zearalenone was characterized 
from the zearalenone utilizer Pseudomonas putida strain ZEA-1, in which ZEA transformed into product with less or not 
toxic. A 5.5 kilobase-pair (kpb) Pst1-Kpn1 fragment containing gene(s) coding for zearalenone degradation was cloned. 
The cloned gene(s) activity was expressed in Escherichia coli, and ZEA degradation by recombinant E. coli was 
relatively rapid and effective, leaving no detectable ZEA after 72 h. In further experiments, cell-free extract of E.coli have 
been used in the same way, both to confirm these observations and the enzymatic nature of the degradation activity. 
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INTRODUCTION 
 
Zearalenone (ZEA) [6-(10-hydroxy-6-oxo-trans-1-
undecenyil)-resorcylic acid lactone] is a mycotoxin 
produced by several species of Fusarium, most notably 
Fusarium  graminearum and F.  culmorum. Zearalenone 
and its derivatives exert estrogenic and anabolic effects 
on mammals. Carryover of zearalenone from infected 
grain to feedstuff causes reproductive problems in pigs, 
sheep, and other farm animals including precocious 
sexual development, vulva enlargement, 
pseudopregnancy, loss of embryos, and reduced litter 
size (Farnworth and Trenholm, 1983; Long and Diekman, 
1986; Green et al., 1990). When digested with grain-
based food, zearalenone may cause hyperestrogenism in 
children (Szuetz et al., 1997)). A part from its 
estrogenicity, zearalenone is genotoxic in mice and is a 
suspected carcinogen (Coe et al., 1992; Grosse et al., 
1990; Pfohl-Leszkowicz et al., 1995). Hence; increasing 
attention has been paid to the development of an 
effective strategy for the decontamination of ZEA. 
Although numerous physical and chemical detoxification 
methods have been tested, none really fulfills the 
necessary efficacy, safety, and cost requirements (Ruy et 
al., 2002). Therefore, the development of biological 
detoxification measures, especially in traditionally 
developed countries fermented food products, is 
essential to improve the safety of these foods for human 
consumption (Sweeney and Dobson, 1999). Several 
studies based on adsorption to appropriate media are 
currently being developed. For example, food grade 
Lactobacillus strains were useful for removing a certain 
amount of ZEA by binding to the cell surface (El-Nezami 
et al., 2002). However, other tools are also needed for 
the development of a more efficient and reliable method.  
Enzymatic detoxification could be an efficient 
method for ZEA detoxification (Megharaj, 1997, Varga, 
2005; Smiley and Draughon, 2004; Utermark and 
Karlovsky, 2007). Kakeya et al. (2002) previously found 
that ZEA is converted to a far less estrogenic product on 
incubation with a fungal strain of Clonostachys rosea. 
The hydrolase responsible for detoxification was purified 
to homogeneity and its gene (designated Zhd101) was 
subsequently isolated (Takahashi-Ando et al., 2002, 
2004).   Recently, we isolated a Pseudomonas putida 
ZEA-1 (pZEA-1) strain in our laboratory, which can 
rapidly transform/detoxify the zearalenone. An enzyme 
capable of transforming a zearalenone and its derivatives, 
including  α-zearalenone and β-zearalenone was 
expressed by genes borne on the large plasmid. We now 
report the molecular cloning of the gene(s) that encodes 
this zearalenone transforming enzyme(s).  
 
MATERIALS AND METHODS 
 
Mycotoxin, Zearalenone, α-zearalenol and β-zearalenol 
were purchased from Sigma Chemical Company (St. 
Louis, MO). All chemicals were at least of analytical-
reagent. Each mycotoxin was dissolved in DMSO 
(10mg/mL) and used as a standard stock solution. 
 
Bacterial strains, plasmids, and media  
 
The bacterial strains and plasmids used are listed in 
Table 1. E. coli DH5α was used as the host strain for 
construction and maintenance of recombinant plasmids 
containing zea degradation genes. E. coli BL21 (DE3) 
(Novagen,Masison, WI, USA) was used for expression of 
the zea genes.  E. coli strains harboring recombinant 
plasmids were grown at 37 °C in 50 mL LB (Luria broth) 
medium (5 g yeast extract, 10 g trypton, and 10 g NaCl in 
1 L distilled water containing ampicillin (Ap) 50 µg/mL). 
Selection minimal salt medium (MSM) utilizing 100 µg/ml 
zearalenone as a sole carbon source contained the 
following gram per liter: (NH4)2SO4, 0.5; MgSO4.7H2O 
0.2; CaCl2, 0.05; Na2HPO4, 2.44, and KH2PO4, 1.52. For Mal. J. Microbiol. Vol 3(2) 2007, pp.29-36 
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plate cultures, the media mentioned above, solidified with 
1.6% (wt/vol) agar, were used. The pH was adjusted to 
6.8 and the medium was sterilized prior to the addition of 
organic substrates. 
 
 
Table 1: Bacterial strains and plasmids used in this study 
 
 
 
Figure 1. Cloning of DNA fragments of pZEA-1 in E. coli, using the vector pUC19 or-18 and localization of the zea-
degradation gene(s). pZEA-1 fragments that when ligated into pUC19-or 18 indicated on the left. At the right 
are shown the phenotypes of E. coli DH5α harboring these plasmids, +, Growth on zearalenone (ZEA) and 
transform it to a new product (Rf 0.09); -, no growth. Relevant restriction sites of the pZEA-1 used for cloning: 
B, BamH1; E, EcoR1; P, Pst1; X, Xba1, and K, Kpn1. 
 
  
Source  Characteristics  Strain or Plasmids 
    Bacterial strains 
(El-Deeb,2005)  Zearalenone degrading soil isolate (zea
+)  P. putida ZEA-1 
Altalhi, 2007  Plasmid-cured derivatives of P. putida ZEA-1 (zea
-)  P. putida ZEA-1 
Gibco,BRL  SupE44  delta Lac U169 (Phi80Lac delta M15 hasd R17 
RecA1 9 yrA 96 Thi-1relAt 
E. coli DH5α 
 
Noagene  Expression vector host  E. coli BL-21(DE3) 
    Plasmids 
32  pMB1 replicon, LacZ' Ap
r  pUC18 
32  pMB1 replicon, LacZ' Ap
r  pUC19 
Novagene  Expression vector  pET5a 
Altalhi,2007  Plasmid isolated from P. putida ZEA-1, 120 kb  pZEA-1 
This study  8.6 kb BamH1 fragment insert of pZEA-1 insert cloned into 
pUC18 
pZEA-2 
This study  8.6 kb BamH1 fragment insert of pZEA-1 cloned into pUC19  pZEA-3 
This study  5.5-kb Pst1-Kpn1 fragment insert cloned in pUC18 or pUC19  pZEA-4 
This study  5.5-kb Pst1-Kpn1 fragment insert cloned from pUC18 into 
expression vector pET5a 
pZEA-4a 
This study  5.5-kb Pst1-Kpn1 fragment insert cloned from pUC19 into 
expression vector pET5a 
pZEA-4b 
This study  3.2-Kb BamH1-Xba1 fragment fragment insert cloned in 
pUC18 or pUC19        
pZEA-5 
This study  4.2-Kb Sph1-BamH1 fragment fragment insert cloned in 
pUC18 or pUC19 
pZEA-6 
This study  4.2 Kb BamH1-Sph1 fragment fragment insert cloned in 
pUC18 or pUC19 
pZEA-7 
This study  3.9 EcoR1 fragment fragment insert cloned in pUC18 or 
pUC19 
pZEA-8 
B B 
B B 
K  P 
B B  X  X 
B S 
B 
E  E 
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Analysis of zearalenones 
 
Concentration of zearalenone in culture broth was 
evaluated by high-performance chromatograph analysis 
as described by (Utermark and Karlovsky, 2007). 
Reverse-phase high-performance liquid chromatography 
(HPLC) with a diod array and mass spectrometric 
detectors was used. The column was a Polaris C18-A (5 
µm, 150 by nm; Varian, Darmstadt, Germany), the mobile 
phase was 55% methanol-45% water-5% acetonitrile, the 
flow rate was 0.2 mL/min, the column temperature was 
40 °C, detection was done with a diod array detector 
(absorbance at 200 to 800 nm), and mass spectrometry 
was done by electrospray in positive mode (scan for a 
mass/charge ratio of 250 to 500). Preparation of sample 
was done by extracting culture supernatants with ethyl 
acetate and removing the solvent on a rotary evaporator. 
The residue was dissolved in the mobile phase. A five 
point calibration curve (0.05; 0.1; 1.0; 10.0 and 20.0 
ng/mL) was prepared with standards of zearalenones 
(Sigma) and regularly checked. The degradation of 
zearalenone was quantified in equivalents of zearalenone 
using the previous calibration curve. 
Thin layer chromatography (TLC) was used for 
qualitative analysis of zearalenone metabolities. Merk 
silica gel 60 F254 plates (thickness, 0.25 nm) were 
developed with solvent system (chloroform/acetone 
(80:20 vol/vol). Metabolities were visualized under 
irradiation and the major metabolities were recovered 
from TLC plates by elution with ethyl acetate. 
 
Preparations, analysis, and cloning of DNA 
 
Plasmid DNA was isolated by the procedure of Kado and 
Liu (1981) in Pseudomonas strains and by Maniatis et al. 
(1982) in E. coli. Cloning and analysis of clones were 
carried out as previously described (Sambrook et al., 
1989), with specific procedures described below. 
Total plasmid DNA, isolated from Pseudomonas 
putida strain ZEA-1, was digested with restriction 
endonuclease BamH1 and ligated to the positive 
selection cloning vector, pUC19 (Yanish-Perron et al., 
1985). Recombinant plasmids were used to transform E. 
coli DH5α, which was then spread on ampicillin-LB agar 
plates. Following overnight incubation at 37 °C, 
transformants were picked and subsequently screened 
for inserted fragments and zearalenone degradation. 
Several subclones were generated by cloning onto 
pUC19 or 18 to locate precise region of zea degradation 
genes. The enzymes EcoR1, Pst1, Sph1, Xba1, and 
Kpn1 and T4 DNA ligase were used for subcloning of 
different DNA fragments. 
 
Biotransformation of Zearalenone by crude enzyme 
of recombinant E. coli 
 
Expression studies were carried out using E. coli BL-21 
(DE3) carrying pZEA-4a. One colony from freshly 
transformed cells was used to inoculate 2 mL medium 
containing 50 µg/mL ampicillin. Optimal production of 
recombinant protein (enzyme) was obtained when mid-
exponential phase cells (OD600 = 0.6) were induced with 
0.4 mM IPTG or ZEA (100 µg/mL) for 5 h at 37 °C.  Cell 
of Pseudomonas putida strain ZEA-1 (pZEA-1), grown in 
LB or Zea, were harvested in a similar manner. Then the 
cells were harvested by centrifugation (5,000 x g, 10 min, 
and 4 °C), washed twice with10 mM Tris-HCl (pH 7.6) 
and resuspended in 0.01 volume of the same buffer. The 
cells were then disrupted with a sonicator and centrifuged 
at 12,000 x g for 20 min to obtain the supernatant (crude 
enzyme fraction). Enzyme assays were initiated by the 
addition of 100 µL of the crude enzyme fraction to a 
reaction mixture containing 3.66 mL of 10 mM Tris-HCl 
(pH 7.5), 200 µL of zearalenone in 50 mL ethanol (100 
µg/mL). The mixture was incubated in the dark at 30 °C 
without shaking. At selected times, samples were 
centrifuged at 10,000 x g for 5 min, filtered through 0.2 
µm-pore-size Millex filter (Millipore, Bedford, Mass), and 
placed in vials for subsequent TLC and HPLC  analysis 
as described above. Activities of crude enzyme were 
determined by monitoring both degradation of substrate 
and production of the transformed compound.  
The expression of target gene was assessed by 
analysis of total cell protein by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS PAGE) followed 
by Coomassie blue staining. 
Degradation at different temperatures and pH was 
also studied to obtain the optimum temperature and pH 
for the enzyme. Temperatures considered were 10 °C, 20 
°C, 30 °C, and 40 °C over a period of 20 h at pH 7.0  and  
pH considered were  5, 7, 8, 9, and 10 over a period of 
20 h at 30 °C. All experiments were carried out in 
duplicates. Each experiment was terminated by the 
addition of 750 µL ethyl acetate for extraction of the 
remaining ZEA and analysis by HPLC. 
 
Degradation of ZEA and its derivatives by resting 
cells of recombinant E. coli 
  
DH5α harbouring pZEA-4a or pZEA-4b was cultivated in 
5 ml of LB supplemented with Ap at 37 °C with reciprocal 
shaking (120 rpm), and then 100 µL of the culture was 
transferred to 100 mL of the same medium. After 
cultivation at 30 °C with shaking at 120 rpm until the 
optical density at 600 nm (OD600) reached 0.4 to 0.5, 
isopropyl-1-thio-β-D-galactopyranoside [IPTG] was 
added to 0.5 mM and the cells further cultivated at 30 °C 
for 15 h. Then the cells were harvested by centrifugation 
(5,000 x g, 10 min, 4 °C), washed twice with10 mM Tris-
HCL (pH 7.6) and resuspended in the same buffer to an 
OD600 of 12 to 13. Mycotoxins (ZEA, α-zearalenol, or β-
zearalenol) were added to 5 mL cell suspension at a final 
concentration of 100 µg/mL. The reaction mixture was 
incubated on reciprocal shaker at 30 °C. At selected 
times, samples were centrifuged at 10,000 x g for 5 min, 
filtered through 0.2 µm-pore-size Millex filter (Millipore, 
Bedford, Mass), and placed in vials for subsequent 
analysis. The culture supernatants were acidified, 
extracted with ethyl acetate and then analyzed by TLC. 
The remaining zearalenone was also extracted from the Mal. J. Microbiol. Vol 3(2) 2007, pp.29-36 
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supernatants and quantified by HPLC as described 
previously. 
 
Toxicity Bioassay 
 
The toxicity of zearalenones and its degradative products 
were compared by bioassay against Artemia  salina 
based on the method of Harwig and Scott (1971). In the 
bioassays, groups of 10 to 20 larvae were exposed to a 
range of concentrations of different zearalenone 
derivatives in a 96-well microtitration plates. Stock 
concentration of toxin was prepared as described above. 
The final concentration of zeralenone, α-zearalenol, and 
β-zeralenone were 100 µg/mL, which were approximately 
90% lethal concentration (LC90) for the larvae. The toxin 
solutions were then treated with crude enzyme. Groups 
with only toxins solution in wells served as negative 
controls, and those with only crude enzyme served as 
positive control. All treatments were in triplicate and all 
experiments were repeated three times with plates being 
in grown at 28 °C and mortality being evaluated at 28 °C. 
Complete immobility or paralysis was taken as indication 
for neurotoxic activity towards the insect larvae.  
 
 
RESULTS AND DISCUSSION 
 
The zearalenone-specific transforming enzyme is 
plasmid encoded 
 
The natural soil isolate P. putida strain ZEA-1 has been 
shown to convert the mycotoxin zearalenone to a 
compound with low or not toxicity as compared with the 
parent compound (El-Deeb, 2004). This compound has 
specific UV spectra (400 nm) and Rf  value of 0.09. 
Plasmid DNA analysis of Pseudomonas sp. cultures 
grown on 100 µg/mL zearalenone as sole carbon source 
indicated the presence of a single large plasmid element 
(Altalhi, 2007). This plasmid was designated as pZEA-1 
of approximately 120 kb and found to be responsible for 
ZEA degradation. This was based on the fact that the 
plasmid cured strain showed ZEA
- phenotype and the 
ZEA
+ phenotype could be conjugally transferred (Altalhi, 
2007).  
 
Cloning and localization of ZEA degradation gene in 
pZEA-1 
 
Total plasmid DNA isolated from strain ZEA-1 was 
digested with restriction enzyme BamH1 and ligated to 
the positive selection cloning vector, pUC19. 
Recombinant plasmids were used to transform E. coli 
DH5α, which was then spread on ampicillin-LB agar 
plates, whereby 1500 colonies were picked and screened 
for the insert fragment and ZEA degradation in resting-
cell assays. Analysis of plasmids isolated from the 
responsible transformed DH5α showed that they all 
carried 8.6 kb BamH1 fragment inserted in vector pUC19. 
One of the plasmid was designated pZEA-2 (Figure 1). 
Plasmid pZEA-3, which is the same as pZEA-2 except 
that the 8.6 Kb fragment is inserted in the opposite 
direction on the vector, also exhibited the same catabolic 
activity as pZEA-2 when introduced into E. coli DH5α, 
suggesting that the 8.6 kb fragment carries the zea 
degradation gene(s), including their promoter(s).  
 
Restriction mapping of the 8.6-kb BamH1 fragment 
and further subcloning zea degradation genes 
 
A physical map of the 8.6 kb fragment showing  EcoR1, 
Kpn1, Pst1, Sph1, and Xba1 sites was generated (Figure 
1) and used to develop zea gene(s) subcloning strategies. 
Various fragments were subcloned in pUC19, transferred 
in  E. coli DH5α and the transformants were tested by 
resting-cell assays for their ability to convert zearalenone. 
By assaying all constructs for the formation of the new 
product (Rf 0.09) in the medium, it was postulated that 
the DNA region conferring zea degradation gene(s) 
activity was found to be located within a 5.5 kb Pst1-
Kpn1 fragment (Figure 1). This fragment was cloned into 
pUC19 and pUC18 to create pZEA-4a and pZEA-4b, in 
either of the two possible orientations. Both constructs, 
pZEA-4a and pZEA-4b were transformed E. coli DH5α 
and screened for the insert fragment and ZEA 
degradation activity in resting-cell assays. Both 
constructs were shown to harbour the genes functional 
for the conversion of ZEA to a new product with an RF 
value of 0.09 in whole cell assay experiment (Figure 2). 
This implies that the promoter of the zea gene(s) 
originating from P. putida ZEA-1 is expressed well in E.  
coli strains. This established that the DNA sequences 
representing the gene(s) encoding ZEA catabolism would 
in all probability be present within a 5.5 kb Pst1-Kpn1 
segment.  
To examine whether the subcloned DNA in plasmid 
pZEA-4a or pZEA-4b expressed zea genes by using 
expression vector pTE5a, the 5.5 kb Pst1-Kpn1 fragment 
was cloned into pTE5a in either possible orientation and 
create pZEA-4az and pZEA-4bz. Both recombinant 
plasmids were transferred into E. coli DH5α and the 
transformants were tested by resting-cell assays for the 
ability to convert zearalenone into a new compound. Both 
pET5a constructs were subsequently transferred into E. 
coli BL21 (DE3) for expression.  
 
Expression of cloned gene in E. coli 
 
Expression studies were carried out using E. coli BL-21 
(DE3) carrying recombinant plasmid described above. 
After induction with IPTG or ZEA, crude cell extracts from 
P. putida strain ZEA-1 (pZEA-1) and from E. coli BL-21 
(DE3) transformed with pZEA-4az or pZEA-4bz were 
evaluated for their ability to remove zearalenone. The 
results in Figure 3 show that the degradation efficiency of 
crude extract obtained from E. coli BL-21 (DE3) 
containing (pZEA-4az or pZEA-4bz) was almost identical 
to that of Pseudomonas sp. strain ZEA-1 (pZEA-1) during 
incubation with zearalenone. No ZEA degradation activity 
was observed with wild type E. coli BL-21(DE3) (Figure 
2). Also, crude extract from P. putida strain ZEA-1 and Mal. J. Microbiol. Vol 3(2) 2007, pp.29-36 
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from  E. coli BL-21 (DE3) (pZEA-4az or pZEA-4bz) 
converted ZEA (Rf = 0.64) into a product that had an Rf 
value of .09 (Figure 2). Under the same condition, 
extracts from the control E. coli (i.e. without the 
recombinant plasmid) did not show ZEA conversion 
activity (Figure 2). Evidence of the expression of zea 
gene(s) in E. coli either driven by the promoters 
contained in cloned DNA or through the promoter of 
plasmid vector pTE5a was obtained by cloning of Pst1-
Kpn1 fragment of plasmid pZEA-2 in expression pET5a 
vector in either orientation, indicating that cloned DNA 
has promoter-like sequence that are recognized by E. 
coli RNA polymerase  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  TLC detection of ZEA degradation in a resting 
cell system and crude extract. Lane 1, ZEA 
incubated with resting cells of wild type 
Pseudomonas sp. ZEA-1 (pZEA-1); lane 2, 
ZEA incubated with resting cells of   
recombinant E. coli DH5α (pZEA-4a), Lane 3, 
ZEA incubated with resting cells of   
recombinant E. coli DH5α (pZEA-4b), Lane 4,  
ZEA incubated with crude extract of P. putida 
(pZEA-1), Lane 5, ZEA incubated with crude 
extract of  E. coli BL21 (DE3) (pZEA-4az),   
Lane  6, ZEA incubated with crude extract of  
E. coli BL21 (DE3) (pZEA-4bz), Lane 7, ZEA 
Incubated with crude extract of wild type E. 
coli BL21(DE3) (plasmidless, ZEA
-), and Lan 
8,  ZEA standard. 
 
Subsequently, the cell extract were then subjected to 
SDS-polyacrylamide gel electrophoresis. The protein was 
produced so abundantly in E. coli that could be readily 
visualized in conventional Coomassie blue-stained SDS-
polyacrylamide gels. Figure 4 (lane 2) shows the protein 
profile of E. coli Bl-21 containing the plasmid vector 
pTE5a (negative control). The protein synthesized by 
strain BL-21 containing recombinant plasmid is shown in 
Figure 4 (lane 3). The results shown in Figure 4 (lane3) 
indicate two polypeptides with different molecular weight. 
This variation in peptides could be attributed to a number 
of gene products were expressed and involved in zea 
degradation. 
The effect of different temperature and pH on the 
loss of ZEA by crude protein extracts of recombinant 
bacterial strain was also evaluated. After incubation time 
of 24 h at 10, 20, 30, 37 and 50 °C, the residual ZEA-
content were determined as shown in Figure 5. The 
recombinant strain of E. coli showed an optimum at 30 -
37 °C. These results are in agreement with results 
obtained by Takahashi-Ando et al. (2004) who found that 
the optimum temperature for zea degradation enzyme 
was 37 °C and it was rapidly inactivated at 50 °C. 
Solution pH also affected the amount of ZEA degraded 
by crude protein extracts after 24 h. maximum 
degradation was observed at pH 7-8 (pH levels: 5, 6, 7, 8, 
and 10), with some ZEA degradation occurring at pH as 
low as 5 and as high as 10 (Figure 6) (Smiley and 
Draughon, 2004). In contrast to our results, Takahashi-
Ando et al. 2004 found that the optimum pH for the same 
enzyme is 10.5. This difference in the nature of enzyme 
activity towards pH may be attributed to the different 
source of enzyme. 
0 5 10 15 20 25
0
20
40
60
80
100
Z
e
a
r
a
l
e
n
o
n
e
 
r
e
m
a
i
n
i
n
g
 
(
%
)
Time (hr)
 
Figure 3: Zearalenone degradation kinitics observed 
over a period of 24 h using cell-free extracts 
of recombinant E. coli BL21 (DE3). Cell 
extracts of E. coli BL21 (DE3) (pZEA-4a), 
(▲); Cell extract of wild type E. coli BL21 
(DE3), (■); Cell extracts of   P. putida ZEA-1 
(pZEA-1), (∆) , and Cell extract of  P. putida 
ZEA-1M (plasmidless), (□). Cell extracts 
were obtained in a sonication process and 
the remaining of ZEA were measured by 
HPLC at appropriate time. 
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Figure 4: SDS PAGE image exhibiting various protein 
profiles. Lane 1, size marker; lane 2, E. coli 
BL-21 containing plasmid vector PTE5a 
(negative control); lane 3, E. coli BL-21 
containing recombinant plasmid  
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Figure 5: Zearalenone degradation at different 
temperature using cell free extracts from 
E.coli BL21 (DE3) (pZEA-4), (■), and P. 
putida (pZEA-1), (□). The reaction was 
carried out at 25 °C, 30
 °C, 37 °C, and 50
 
°C.  The remaining of ZEA was measured 
by HPLC at appropriate time. 
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Figure 6: Zearalenone degradation at different pH using 
cell free extracts from E. coli BL21 (DE3) 
(pZEA-4), (■), and P. putida (pZEA-1), (□).The 
remaining of ZEA were measured by HPLC at 
appropriate time. 
 
Detoxification of ZEA and its derivatives by 
recombinant bacteria 
 
Recombinant E. coli DH5α cells carrying (pZEA-4a) was 
tested for their ability to remove ZEA and its derivatives 
from liquid medium (Figure 7). Wild-type or recombinant 
E. coli cells grown in presence of IPTG were 
supplemented with 100 µg of zearalenone, α-zearalenol, 
or  β-zearalenol per mL. The wild type bacteria 
metabolized neither ZEA nor its derivatives, and the 
mycotoxins were fully recovered as nontransformed from 
the media (Figure 2), it was not absorbed or adsorbed to 
bacterial cells (data not shown). On the other hand, an 
IPTG induced culture of recombinant bacteria carrying 
pZEA-4 completely removed ZEA and its derivatives from 
the media. However, the degradation of α-zearalenol by 
recombinant  E. coli was quite inefficiently compared to 
the degradation of ZEA and β-zearalenol. From TLC 
analysis of supernatant, we were able to detect the 
degradation product of ZEA with an Rf of 0.09 (Figure 2). 
Takahashi-Ando et al. (2002) cloned and characterized a 
ZEA-detoxifying gene, zhd101, from fungus 
Clonostachys rosea which convert ZEA to nonestrogenic 
product and remove zearalenone and its derivatives from 
culture media. 
 
Bioassay 
 
The bioassay was performed three times in triplicate. The 
results shown in Table 2 represents one of the 
experiments. Crude enzyme was highly efficient in 
degrading toxin-allowing survival of larvae at low 
concentration (0.1 mg cell protein). Mortality of the test 
organisms is a sensitive end-point for the assessment of 
          1                     2                     3              4            
A 
B 
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the ecotoxicological risk by the environmental pollutants. 
Accordingly, the microbial biotransformation mediated 
decrease in the toxicity of the test compounds has been 
taken as an index of their biological treatment (Lenke et 
al., 1998).  In this study, the toxicity of the residual 
zearalenone, along with the metabolites formed after 
their crude extract treatment, was evaluated by using test 
organism A. salina. It was observed that the degradation 
of zearalenone and its isomers was accompanied by a 
substantial reduction in their toxicity to the test organisms 
(Table 2). After 6 and 12 h of incubation with crude 
enzyme, 85 to 100 % of larvae survived respectively 
(Table 2).  This finding suggests that the crude enzyme 
mediates the metabolism of zearalenone and the formed 
metabolites are less toxic (Kakeya et al., 2002). 
Accordingly, the crude enzyme can be used for the 
bioremediation of zearalenones. 
 
Table 2: Approximate survival rates of A. salina larvae 
exposed to toxin solution 
 
 
CONCLUSIONS 
 
Genes specifying degradation of zearalenone in P. putida 
ZEA-1 was studied for the purpose of understanding their 
localization in this bacterium. This goal was partially 
achieved by subcloning the zea genes that specify 
degradation/detoxification of ZEA from previously 
reported plasmid pZEA-1 (Altalhi, 2007). The relative 
position of zea genes expressed in E. coli and mapped 
by restriction enzymes analysis, and the bound aeries of 
DNA encoding the zea genes were established on 5.5-Kb 
DNA fragment (Figure 1). Takahashi-Ando et al. (2002) 
reported similar finding of zea gene cloned from fungus 
Clonostachys rosea and expressed in E. coli. However, 
the size and restriction map of zhd101 differed from 
cloned DNA fragment of the P. putida ZEA-1.  
Evidence of the expression of zea genes in E. coli 
either driven by the promoters contained in the cloned 
DNA or through the promoter of expression vector was 
obtained by cloning the 5.5 kb Pst1-Kpn1 fragment of 
plasmid pZEA-2 in expression vector pTE5a. The 
resulting plasmid, pZEA-4az or pZEA-4bz, expressed zea 
genes in either orientation, indicating the cloned DNA 
fragment has promoter-like sequence that are recognized 
by E. coli RNA polymerase. 
Comparison of the degradation product by zea 
genes, which has Rf value of 0.09 and UV maxima 
spectra at 400 nm (Altalhi, 2007) with a product (Rf 0.2) 
produced by zhd101 gene (Takahashi-Ando et al., 2002) 
may be attributed to further zearalenoe degradation by 
zea genes than only cleavage of lactone ring by zhd101 
enzyme (Takahashi-Ando et al., 2002). Since more than 
one proteins induced through growth of recombinant E. 
coli on zearalenoe, this suggests that a number of genes 
products were expressed and involved in zea 
degradation. However, the close link between these 
gene(s) and the fact that we were unable to separate 
these gene(s) on the 5.5 kb fragment may indicate that 
the genes are organized in a complex structure. It is not 
unusual that degradative genes are clustered in one or 
more large operons in bacteria (Horn et al., 1991). It has 
also been suggested that a few common self-
transmissible ancestor replicon were involved in the 
acquisition and spread of different catabolic modules in 
the environment (van der Meer et al., 1992).  
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Figure 7: Degradation of zearalenone and its derivatives 
by resting cells of recombinant E.coli DH5α 
(pZEA-4). Mycotoxins were included in MSM 
medium at a concentration of 100 µg/mL.:   
(▲), ZEA; (○), α-zearalenol; (∆), β-zearalenol; 
and (●), ZEA incubated with no bacteria. The 
remaining of ZEA were measured by HPLC at 
appropriate time 
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